These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 9804914)
1. The interaction of Staphylococcus aureus bi-component gamma-hemolysins and leucocidins with cells and lipid membranes. Ferreras M; Höper F; Dalla Serra M; Colin DA; Prévost G; Menestrina G Biochim Biophys Acta; 1998 Nov; 1414(1-2):108-26. PubMed ID: 9804914 [TBL] [Abstract][Full Text] [Related]
2. Protein engineering modulates the transport properties and ion selectivity of the pores formed by staphylococcal gamma-haemolysins in lipid membranes. Comai M; Dalla Serra M; Coraiola M; Werner S; Colin DA; Monteil H; Prévost G; Menestrina G Mol Microbiol; 2002 Jun; 44(5):1251-67. PubMed ID: 12068809 [TBL] [Abstract][Full Text] [Related]
3. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Prévost G; Cribier B; Couppié P; Petiau P; Supersac G; Finck-Barbançon V; Monteil H; Piemont Y Infect Immun; 1995 Oct; 63(10):4121-9. PubMed ID: 7558328 [TBL] [Abstract][Full Text] [Related]
4. Composition of staphylococcal bi-component toxins determines pathophysiological reactions. König B; Prévost G; König W J Med Microbiol; 1997 Jun; 46(6):479-85. PubMed ID: 9350200 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding. Meyer F; Girardot R; Piémont Y; Prévost G; Colin DA Infect Immun; 2009 Jan; 77(1):266-73. PubMed ID: 18838523 [TBL] [Abstract][Full Text] [Related]
6. A predicted beta-sheet from class S components of staphylococcal gamma-hemolysin is essential for the secondary interaction of the class F component. Meunier O; Ferreras M; Supersac G; Hoeper F; Baba-Moussa L; Monteil H; Colin DA; Menestrina G; Prévost G Biochim Biophys Acta; 1997 Jun; 1326(2):275-86. PubMed ID: 9218558 [TBL] [Abstract][Full Text] [Related]
7. The structure of a Staphylococcus aureus leucocidin component (LukF-PV) reveals the fold of the water-soluble species of a family of transmembrane pore-forming toxins. Pédelacq JD; Maveyraud L; Prévost G; Baba-Moussa L; González A; Courcelle E; Shepard W; Monteil H; Samama JP; Mourey L Structure; 1999 Mar; 7(3):277-87. PubMed ID: 10368297 [TBL] [Abstract][Full Text] [Related]
8. Channel-forming leucotoxins from Staphylococcus aureus cause severe inflammatory reactions in a rabbit eye model. Siqueira JA; Speeg-Schatz C; Freitas FI; Sahel J; Monteil H; Prévost G J Med Microbiol; 1997 Jun; 46(6):486-94. PubMed ID: 9350201 [TBL] [Abstract][Full Text] [Related]
9. Staphylococcus aureus bicomponent gamma-hemolysins, HlgA, HlgB, and HlgC, can form mixed pores containing all components. Dalla Serra M; Coraiola M; Viero G; Comai M; Potrich C; Ferreras M; Baba-Moussa L; Colin DA; Menestrina G; Bhakdi S; Prévost G J Chem Inf Model; 2005; 45(6):1539-45. PubMed ID: 16309251 [TBL] [Abstract][Full Text] [Related]
10. Ion channels and bacterial infection: the case of beta-barrel pore-forming protein toxins of Staphylococcus aureus. Menestrina G; Dalla Serra M; Comai M; Coraiola M; Viero G; Werner S; Colin DA; Monteil H; Prévost G FEBS Lett; 2003 Sep; 552(1):54-60. PubMed ID: 12972152 [TBL] [Abstract][Full Text] [Related]
11. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Kaneko J; Kamio Y Biosci Biotechnol Biochem; 2004 May; 68(5):981-1003. PubMed ID: 15170101 [TBL] [Abstract][Full Text] [Related]
12. Leukocidal toxins of staphylococci. Szmigielski S; Prévost G; Monteil H; Colin DA; Jeljaszewicz J Zentralbl Bakteriol; 1999 Apr; 289(2):185-201. PubMed ID: 10360319 [TBL] [Abstract][Full Text] [Related]
13. Homologous versus heterologous interactions in the bicomponent staphylococcal gamma-haemolysin pore. Viero G; Cunaccia R; Prévost G; Werner S; Monteil H; Keller D; Joubert O; Menestrina G; Dalla Serra M Biochem J; 2006 Feb; 394(Pt 1):217-25. PubMed ID: 16241903 [TBL] [Abstract][Full Text] [Related]
14. Bi-component HlgC/HlgB and HlgA/HlgB γ-hemolysins from S. aureus: Modulation of Ca Staali L; Colin DA Toxicon; 2021 Oct; 201():74-85. PubMed ID: 34411591 [TBL] [Abstract][Full Text] [Related]
15. Structurally designed attenuated subunit vaccines for S. aureus LukS-PV and LukF-PV confer protection in a mouse bacteremia model. Karauzum H; Adhikari RP; Sarwar J; Devi VS; Abaandou L; Haudenschild C; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Warfield KL; Shulenin S; Aman MJ PLoS One; 2013; 8(6):e65384. PubMed ID: 23762356 [TBL] [Abstract][Full Text] [Related]
16. Antibodies to S. aureus LukS-PV Attenuated Subunit Vaccine Neutralize a Broad Spectrum of Canonical and Non-Canonical Bicomponent Leukotoxin Pairs. Adhikari RP; Kort T; Shulenin S; Kanipakala T; Ganjbaksh N; Roghmann MC; Holtsberg FW; Aman MJ PLoS One; 2015; 10(9):e0137874. PubMed ID: 26367030 [TBL] [Abstract][Full Text] [Related]
17. The staphylococcal pore-forming leukotoxins open Ca2+ channels in the membrane of human polymorphonuclear neutrophils. Staali L; Monteil H; Colin DA J Membr Biol; 1998 Apr; 162(3):209-16. PubMed ID: 9543493 [TBL] [Abstract][Full Text] [Related]
18. The gamma-hemolysin locus of Staphylococcus aureus comprises three linked genes, two of which are identical to the genes for the F and S components of leukocidin. Cooney J; Kienle Z; Foster TJ; O'Toole PW Infect Immun; 1993 Feb; 61(2):768-71. PubMed ID: 8423103 [TBL] [Abstract][Full Text] [Related]
19. Above and beyond C5a Receptor Targeting by Staphylococcal Leucotoxins: Retrograde Transport of Panton-Valentine Leucocidin and γ-Hemolysin. Zimmermann-Meisse G; Prévost G; Jover E Toxins (Basel); 2017 Jan; 9(1):. PubMed ID: 28117704 [TBL] [Abstract][Full Text] [Related]
20. Development of Combination Vaccine Conferring Optimal Protection against Six Pore-Forming Toxins of Staphylococcus aureus. Zhang Q; Jiang T; Mao X; Kim JD; Ahn DH; Jung Y; Bae T; Lee BL Infect Immun; 2021 Sep; 89(10):e0034221. PubMed ID: 34227839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]